Greenline Partners LLC cut its stake in Vanguard FTSE Emerging Markets ETF (NYSEARCA:VWO – Get Rating) by 53.2% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 474,349 shares of the exchange traded fund’s stock after selling 539,483 shares during the […]
Greenline Partners LLC lowered its stake in Medtronic plc (NYSE:MDT – Get Rating) by 5.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 33,003 shares of the medical technology company’s stock after selling 2,016 shares during the quarter. Greenline Partners LLC’s holdings […]
Greenline Partners LLC lowered its holdings in Pfizer Inc. (NYSE:PFE – Get Rating) by 29.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 95,045 shares of the biopharmaceutical company’s stock after selling 39,552 shares during the quarter. Greenline Partners LLC’s holdings […]
Greenline Partners LLC cut its position in shares of Duke Energy Co. (NYSE:DUK – Get Rating) by 82.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,638 shares of the utilities provider’s stock after selling 22,178 shares during the […]
Greenline Partners LLC decreased its holdings in Visa Inc. (NYSE:V – Get Rating) by 17.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 26,938 shares of the credit-card processor’s stock after selling 5,794 shares during the quarter. Visa comprises about 1.1% of […]